Akshay Vaishnaw - 10 Feb 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
President
Signature
By: /s/ Cynthia L Anderson, Attorney-in-Fact For: Akshay K. Vaishnaw
Issuer symbol
ALNY
Transactions as of
10 Feb 2023
Transactions value $
-$6,268,805
Form type
4
Filing time
14 Feb 2023, 15:03:39 UTC
Previous filing
07 Dec 2022
Next filing
01 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $1.95M +30.9K +139.87% $63.00 53K 10 Feb 2023 Direct F1
transaction ALNY Common Stock Sale -$364K -1.71K -3.22% $213.13 51.3K 10 Feb 2023 Direct F1, F2
transaction ALNY Common Stock Sale -$494K -2.31K -4.5% $214.28 49K 10 Feb 2023 Direct F1, F3
transaction ALNY Common Stock Sale -$2.22M -10.3K -20.98% $215.59 38.7K 10 Feb 2023 Direct F1, F4
transaction ALNY Common Stock Sale -$4.21M -19.4K -50.23% $216.38 19.3K 10 Feb 2023 Direct F1, F5
transaction ALNY Common Stock Sale -$934K -4.3K -22.32% $217.05 15K 10 Feb 2023 Direct F1, F6
holding ALNY Common Stock 515 10 Feb 2023 by Managed Account F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -30.9K -100% $0.00* 0 10 Feb 2023 Common Stock 30.9K $63.00 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $212.71 to $213.70. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $213.72 to $214.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $214.88 to $215.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $215.89 to $216.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $216.96 to $217.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
F8 The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.